In the DSPH and MSPH groups, a 5 cm long strip of topical gel containing 1% diclofenac sodium (about 26 mg diclofenac sodium) or 15% methyl salicylate (about 395 mg methyl salicylate) was applied from the tube over the target knee.
Baseline characteristics of the patients Characteristics DSPH MSPH TUS F-values p group group group Mean[+ or Mean[+ or Mean[+ or -]SD -]SD -]SD Age (year) 64.
Statistically significant differences regarding improvement changes in primary and secondary outcome measures were found between DSPH and MSPH in all variables (p<0.
The differences regarding improvement changes in primary and secondary outcome measures between groups DSPH and TUS are also reveled in Table 4.
In this randomized controlled study, marked improvements in clinical outcomes were obtained with DSPH, MSPH and conventional TUS in patients with knee OA.
However, only DSPH was found to have better effects compared with conventional TUS.